- Home
- SAVA
as 07-26-2024 4:00pm EST
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 1.1B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 4.8M |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.79 - $32.10 | Next Earning Date: | 08-05-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Cassava Sciences Inc. News
SAVA Breaking Stock News: Dive into SAVA Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Cassava Shares Rise After Incoming Chairman Gives Timeline for Alzheimer's Drug Study Read Out
Motley Fool
4 days ago
Why Cassava Sciences Stock Is Skyrocketing Today
MT Newswires
8 days ago
Cassava Sciences Shares Rise After Court Schedules Hearing on Bonus Plan Lawsuit Settlement
Zacks
8 days ago
Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates
MT Newswires
9 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
Benzinga
9 days ago
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
MT Newswires
9 days ago
Top Midday Decliners
MT Newswires
9 days ago
Cassava Sciences Names Richard Barry Executive Chairman, Launches Search for CEO
Compare SAVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SAVA Cassava Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.